Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Sovleplenib [inn]
2. 9cl6353kho
3. 1415792-84-5
4. (s)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-n-(morpholin-2-ylmethyl)pyrido(4,3-b)pyrazin-5-amine
5. Pyrido[3,4-b]pyrazin-5-amine, 7-[4-[1-(methylsulfonyl)-4-piperidinyl]phenyl]-n-[(2s)-2-morpholinylmethyl]-
6. Unii-9cl6353kho
7. Hmpl523
8. Hmpl-523
9. Hmpl-523 [who-dd]
10. Schembl14242080
11. Gtpl11886
12. Zinc143715528
13. Compound 225 [wo2012167733a1]
14. Hy-145598
15. Cs-0376654
16. F78019
17. (s)-7-(4-(1-(methylsulfonyl)piperidin-4-yl)phenyl)-n-(morpholin-2-ylmethyl)pyrido[3,4-b]pyrazin-5-amine
| Molecular Weight | 482.6 g/mol |
|---|---|
| Molecular Formula | C24H30N6O3S |
| XLogP3 | 1.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 482.21001001 g/mol |
| Monoisotopic Mass | 482.21001001 g/mol |
| Topological Polar Surface Area | 118 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 748 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Sovleplenib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Sovleplenib, including repackagers and relabelers. The FDA regulates Sovleplenib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Sovleplenib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Sovleplenib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Sovleplenib supplier is an individual or a company that provides Sovleplenib active pharmaceutical ingredient (API) or Sovleplenib finished formulations upon request. The Sovleplenib suppliers may include Sovleplenib API manufacturers, exporters, distributors and traders.
click here to find a list of Sovleplenib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Sovleplenib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Sovleplenib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Sovleplenib GMP manufacturer or Sovleplenib GMP API supplier for your needs.
A Sovleplenib CoA (Certificate of Analysis) is a formal document that attests to Sovleplenib's compliance with Sovleplenib specifications and serves as a tool for batch-level quality control.
Sovleplenib CoA mostly includes findings from lab analyses of a specific batch. For each Sovleplenib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Sovleplenib may be tested according to a variety of international standards, such as European Pharmacopoeia (Sovleplenib EP), Sovleplenib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Sovleplenib USP).
LOOKING FOR A SUPPLIER?
